These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 32635537)

  • 1. Absolute Binding Free Energy Calculations for Highly Flexible Protein MDM2 and Its Inhibitors.
    Singh N; Li W
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32635537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revealing binding selectivity of ligands toward murine double minute 2 and murine double minute X based on molecular dynamics simulations and binding free energy calculations.
    Shi S; Sui K; Liu W; Lei Y; Zhang S; Zhang Q
    J Biomol Struct Dyn; 2020 Oct; 38(17):5081-5094. PubMed ID: 31755361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of binding free energy calculations to prediction of binding modes and affinities of MDM2 and MDMX inhibitors.
    Lee HS; Jo S; Lim HS; Im W
    J Chem Inf Model; 2012 Jul; 52(7):1821-32. PubMed ID: 22731511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing the Free-Energy Landscape of MDM2 Protein-Ligand Interactions by Steered Molecular Dynamics Simulations.
    Hu G; Xu S; Wang J
    Chem Biol Drug Des; 2015 Dec; 86(6):1351-9. PubMed ID: 26032728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing Origin of Binding Difference of inhibitors to MDM2 and MDMX by Polarizable Molecular Dynamics Simulation and QM/MM-GBSA Calculation.
    Chen J; Wang J; Zhang Q; Chen K; Zhu W
    Sci Rep; 2015 Nov; 5():17421. PubMed ID: 26616018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to deal with multiple binding poses in alchemical relative protein-ligand binding free energy calculations.
    Kaus JW; Harder E; Lin T; Abel R; McCammon JA; Wang L
    J Chem Theory Comput; 2015 Jun; 11(6):2670-9. PubMed ID: 26085821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular modeling and molecular dynamics simulation studies on pyrrolopyrimidine-based α-helix mimetic as dual inhibitors of MDM2 and MDMX.
    Lu SY; Jiang YJ; Zou JW; Wu TX
    J Mol Graph Model; 2011 Sep; 30():167-78. PubMed ID: 21820342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How Does the Recently Discovered Peptide MIP Exhibit Much Higher Binding Affinity than an Anticancer Protein p53 for an Oncoprotein MDM2?
    Yamada T; Hayashi T; Hikiri S; Kobayashi N; Yanagawa H; Ikeguchi M; Katahira M; Nagata T; Kinoshita M
    J Chem Inf Model; 2019 Aug; 59(8):3533-3544. PubMed ID: 31282659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calculation of hot spots for protein-protein interaction in p53/PMI-MDM2/MDMX complexes.
    Huang D; Qi Y; Song J; Zhang JZH
    J Comput Chem; 2019 Apr; 40(9):1045-1056. PubMed ID: 30549062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational studies and peptidomimetic design for the human p53-MDM2 complex.
    Zhong H; Carlson HA
    Proteins; 2005 Jan; 58(1):222-34. PubMed ID: 15505803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designing dual inhibitors of Mdm2/MdmX: Unexpected coupling of water with gatekeeper Y100/99.
    Lee XA; Verma C; Sim AYL
    Proteins; 2017 Aug; 85(8):1493-1506. PubMed ID: 28425639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Simulations Identify Binding Poses and Approximate Affinities of Stapled α-Helical Peptides to MDM2 and MDMX.
    Morrone JA; Perez A; Deng Q; Ha SN; Holloway MK; Sawyer TK; Sherborne BS; Brown FK; Dill KA
    J Chem Theory Comput; 2017 Feb; 13(2):863-869. PubMed ID: 28042965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational changes of the p53-binding cleft of MDM2 revealed by molecular dynamics simulations.
    Espinoza-Fonseca LM; Trujillo-Ferrara JG
    Biopolymers; 2006 Nov; 83(4):365-73. PubMed ID: 16817233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsecond simulations of mdm2 and its complex with p53 yield insight into force field accuracy and conformational dynamics.
    Pantelopulos GA; Mukherjee S; Voelz VA
    Proteins; 2015 Sep; 83(9):1665-76. PubMed ID: 26138282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large scale free energy calculations for blind predictions of protein-ligand binding: the D3R Grand Challenge 2015.
    Deng N; Flynn WF; Xia J; Vijayan RS; Zhang B; He P; Mentes A; Gallicchio E; Levy RM
    J Comput Aided Mol Des; 2016 Sep; 30(9):743-751. PubMed ID: 27562018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integrated in silico screening strategy for identifying promising disruptors of p53-MDM2 interaction.
    Sirous H; Chemi G; Campiani G; Brogi S
    Comput Biol Chem; 2019 Dec; 83():107105. PubMed ID: 31473433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the Flexible Regions of the Oncoprotein Mouse Double Minute X on Inhibitor Binding Affinity.
    Qin L; Liu H; Chen R; Zhou J; Cheng X; Chen Y; Huang Y; Su Z
    Biochemistry; 2017 Nov; 56(44):5943-5954. PubMed ID: 29023092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ensemble-based virtual screening reveals dual-inhibitors for the p53-MDM2/MDMX interactions.
    Barakat K; Mane J; Friesen D; Tuszynski J
    J Mol Graph Model; 2010 Feb; 28(6):555-68. PubMed ID: 20056466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-Ligand Binding Free Energy Calculations with FEP.
    Wang L; Chambers J; Abel R
    Methods Mol Biol; 2019; 2022():201-232. PubMed ID: 31396905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SAMPL7 TrimerTrip host-guest binding affinities from extensive alchemical and end-point free energy calculations.
    Huai Z; Yang H; Li X; Sun Z
    J Comput Aided Mol Des; 2021 Jan; 35(1):117-129. PubMed ID: 33037549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.